Publications by authors named "Elizabeth D Williams"

73 Publications

Apocryphal FADS2 activity promotes fatty acid diversification in cancer.

Cell Rep 2021 Feb;34(6):108738

School of Chemistry and Physics, Queensland University of Technology, Brisbane, QLD 4000, Australia; Central Analytical Research Facility, Institute for Future Environments, Queensland University of Technology, 2 George St., Brisbane, QLD 4000, Australia. Electronic address:

View Article and Find Full Text PDF
February 2021

Exclusion Zone Phenomena in Water-A Critical Review of Experimental Findings and Theories.

Int J Mol Sci 2020 Jul 17;21(14). Epub 2020 Jul 17.

School of Biomedical Sciences, Faculty of Health, Institute of Health and Biomedical Innovation, QUT, Australian Prostate Cancer Research Centre-Queensland, Translational Research Institute, Brisbane, QLD 4059, Australia.

View Article and Find Full Text PDF
July 2020

FGFR2c Mesenchymal Isoform Expression Is Associated with Poor Prognosis and Further Refines Risk Stratification within Endometrial Cancer Molecular Subtypes.

Clin Cancer Res 2020 Sep 15;26(17):4569-4580. Epub 2020 May 15.

Queensland University of Technology, School of Biomedical Sciences, Faculty of Health, Institute of Health and Biomedical Innovation, located at the Translational Research Institute, PA Hospital Campus, 37 Kent St Woolloongabba, Brisbane, Queensland, Australia.

View Article and Find Full Text PDF
September 2020

ADAMTS-15 Has a Tumor Suppressor Role in Prostate Cancer.

Biomolecules 2020 04 28;10(5). Epub 2020 Apr 28.

School of Medicine, Deakin University, Waurn Ponds, VIC 3216, Australia.

View Article and Find Full Text PDF
April 2020

Controversies around epithelial-mesenchymal plasticity in cancer metastasis.

Nat Rev Cancer 2019 12 30;19(12):716-732. Epub 2019 Oct 30.

Institute of Health and Biomedical Innovation and School of Biomedical Sciences, Queensland University of Technology (QUT), Brisbane, Queensland, Australia.

View Article and Find Full Text PDF
December 2019

Applications of RNA from circulating tumor cells.

Front Biosci (Landmark Ed) 2020 01 1;25:874-892. Epub 2020 Jan 1.

School of Biomedical Sciences and Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute.37 Kent St, Woolloongabba QLD 4102.

View Article and Find Full Text PDF
January 2020

Microenvironment engineering of osteoblastic bone metastases reveals osteomimicry of patient-derived prostate cancer xenografts.

Biomaterials 2019 11 31;220:119402. Epub 2019 Jul 31.

Institute of Health and Biomedical Innovation (IHBI), Queensland University of Technology (QUT), Brisbane, QLD, Australia; Australian Prostate Cancer Research Centre, Queensland (APCRC-Q), QUT, Brisbane, QLD, Australia; Translational Research Institute (TRI), QUT, Brisbane, QLD, Australia; Centre in Regenerative Medicine, IHBI, QUT, Kelvin Grove, QLD, Australia; School of Biomedical Sciences, Faculty of Health, QUT, Brisbane, QLD, Australia. Electronic address:

View Article and Find Full Text PDF
November 2019

Insulin Enhances Migration and Invasion in Prostate Cancer Cells by Up-Regulation of FOXC2.

Front Endocrinol (Lausanne) 2019 17;10:481. Epub 2019 Jul 17.

Queensland University of Technology (QUT), Australian Prostate Cancer Research Centre-Queensland, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Faculty of Health, Translational Research Institute, Brisbane, QLD, Australia.

View Article and Find Full Text PDF
July 2019

Correction: A molecular portrait of epithelial-mesenchymal plasticity in prostate cancer associated with clinical outcome.

Oncogene 2019 03;38(13):2436

Australian Prostate Cancer Research Centre-Queensland, Institute of Health and Biomedical Innovation, Faculty of Health, School of Biomedical Sciences, Queensland University of Technology, Princess Alexandra Hospital, Translational Research Institute, Brisbane, QLD, Australia.

View Article and Find Full Text PDF
March 2019

NOX2 oxidase expressed in endosomes promotes cell proliferation and prostate tumour development.

Oncotarget 2018 Oct 23;9(83):35378-35393. Epub 2018 Oct 23.

Infection and Immunity Program, Biomedicine Discovery Institute, Department of Pharmacology, Monash University, Melbourne, Victoria 3800, Australia.

View Article and Find Full Text PDF
October 2018

Humanization of the Prostate Microenvironment Reduces Homing of PC3 Prostate Cancer Cells to Human Tissue-Engineered Bone.

Cancers (Basel) 2018 Nov 13;10(11). Epub 2018 Nov 13.

Centre in Regenerative Medicine, Institute of Health and Biomedical Innovation, Queensland University of Technology (QUT), 60 Musk Avenue, Kelvin Grove, Brisbane, QLD 4059, Australia.

View Article and Find Full Text PDF
November 2018

A molecular portrait of epithelial-mesenchymal plasticity in prostate cancer associated with clinical outcome.

Oncogene 2019 02 7;38(7):913-934. Epub 2018 Sep 7.

Australian Prostate Cancer Research Centre-Queensland, Institute of Health and Biomedical Innovation, Faculty of Health, School of Biomedical Sciences, Queensland University of Technology, Princess Alexandra Hospital, Translational Research Institute, Brisbane, QLD, Australia.

View Article and Find Full Text PDF
February 2019

The extracellular matrix in cancer progression: Role of hyalectan proteoglycans and ADAMTS enzymes.

Cancer Lett 2017 01 10;385:55-64. Epub 2016 Nov 10.

School of Medicine, Deakin University, Waurn Ponds, Victoria 3216, Australia; Centre for Molecular and Medical Research, Deakin University, Waurn Ponds, Victoria 3216, Australia. Electronic address:

View Article and Find Full Text PDF
January 2017

Repositioning "old" drugs for new causes: identifying new inhibitors of prostate cancer cell migration and invasion.

Clin Exp Metastasis 2016 Apr 1;33(4):385-99. Epub 2016 Mar 1.

Australian Prostate Cancer Research Centre-Queensland, School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia.

View Article and Find Full Text PDF
April 2016

Identification of a novel fusion transcript between human relaxin-1 (RLN1) and human relaxin-2 (RLN2) in prostate cancer.

Mol Cell Endocrinol 2016 Jan 21;420:159-68. Epub 2015 Oct 21.

Institute of Health and Biomedical Innovation, Australian Prostate Cancer Research Centre-Queensland, Queensland University of Technology/Translational Research Institute, Brisbane, QLD, Australia; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address:

View Article and Find Full Text PDF
January 2016